blog | Latigo Biotherapeutics

Skip to content

Login

Login

Subscribe to our Newsletter

Go Back to Home

Go Back to Blog

IPOs, 2026, Biotech, Latigo Biotherapeutics, Biotherapeutics

Latigo Biotherapeutics (LTGO) Eyes $272 Million IPO to Advance Next-Generation Non-Opioid Pain Medicines

Eric Friedman

Aug 3, 2026, 5:13:40 PM

Thousand Oaks, California-based Latigo Biotherapeutics has filed for a Nasdaq IPO seeking to raise a...

Subscribe to our Newsletter

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.

Copyright © 2025